Boji Medical’s FCZR Approved for Otomycosis Trials – First Liquid Eardrop in China
Boji Medical Technology Co., Ltd. (SHE: 300404) has secured approval from the National Medical Products...
SHE: 300404
Boji Medical’s Huasheng Transfers Glucosamine Sulfate Capsules Technology to Panlong
On March 20, 2025, Boji Medical Technology Co., Ltd (known as Boji Biomedicals) (SHE: 300404)...
Boji Medical Technology Receives NMPA Approval for TBA Clinical Study in Drug-Resistant Tuberculosis
China-based Clinical Research Organization (CRO) Boji Medical Technology Co., Ltd. (SHE: 300404) has announced receiving...
Guangzhou Boji Medical and CapitalBio Pharma Form Joint Venture to Innovate in Traditional Chinese Medicine
Guangzhou Boji Medical Biotechnological Co., Ltd, a Clinical Research Organization (CRO) based in China and...